MTSI — MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC - US
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying MTSI?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their MTSI position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime). 0 congressional purchases, 2 sales disclosed in the last 6 months.
- +3 tracked investors reported holding MTSI at their latest filing
- +Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −Congressional disclosures lean toward selling (2 sales vs 0 purchases, 6 months)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.
About MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC - US (MTSI)
MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC - US (MTSI) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $284M. Across recent filings, tracked investors recorded 2 new positions, 2 increased, 3 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in MTSI
How many top investors track MTSI
A small number of top investors own this.
MTSI Ownership Composition
How MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC - US is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant91.5%
- Macro8.5%
Tracked investors currently reporting MTSI
2 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares272.5KValue$103.7M% Portfolio0.01%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares433.3KValue$164.8M% Portfolio0.06%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares65.5KValue$24.9M% Portfolio0.03%
Previously held MTSI
These investors reported MTSI in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Steve Cohen | Point72 Asset Management | 575.4K | $71.6M | Sep 30, 2025 |
| Ray Dalio | Bridgewater Associates | 76.5K | $7.3M | Mar 31, 2024 |
Recent activity
- New$7.3MMay 14, 2024
- Sold$0(-100.00%)Aug 14, 2024
- Increased$284.3M(173.87%)Nov 14, 2024
- Reduced$256.2M(-22.81%)Feb 14, 2025
- Increased$278.6M(40.71%)Jul 21, 2025
- Reduced$147.4M(-62.94%)Aug 14, 2025
- Reduced$71.6M(-44.06%)Nov 14, 2025
- Sold$0(-100.00%)Feb 17, 2026
- New$104MSep 16, 2024
Frequently asked questions
- How many institutional investors hold MTSI?
- 3 tracked institutional investors disclosed a position in MTSI (MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC - US) in their most recent 13F filing.
- Who is the largest institutional holder of MTSI?
- Steve Cohen, Point72 Asset Management, holds the largest disclosed position in MTSI, valued at $284M.
- Did institutional ownership of MTSI increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 2 increased, 3 reduced, and 2 fully exited MTSI.
- Where does this MTSI ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.